Mais les résultats doivent être attendus longtemps et il n'y a généralement pas de temps azithromycine prix L'autre cas, c'est que l'achat d'un ou d'un autre antibiotique dans une pharmacie classique nécessite des dépenses matérielles considérables et pas toutes les personnes ne peuvent acheter des produits pharmaceutiques aussi coûteux.

Kkgt

Association for Quality Assessment in Section of the Dutch Foundation for Quality Assessment in Medical Laboratories PROGRAM 2013
information
P.O. Box 43100, 2504 AC The Hague, The Netherlands. Tel. +31 70 3217161, Fax + 31 70 3080140,  www.kkgt.nl, E-mail: [email protected] ALCOHOLS/GHB

The program includes 4 tests per year. The samples (4 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
Matrix: liquid bovine serum preserved with 0,1%
ANTICONVULSANTS

The program includes 4 tests per year. The samples (2 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum

ANTIMICROBIAL DRUGS

The program includes 4x2 tests per year. The samples (1 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
BENZODIAZEPINES

The program includes 4 tests per year. The samples (5 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum

CARDIAC DRUGS

The program includes 4 tests per year. The samples (5 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum*

* Because of degradation of amiodarone and desethylamiodarone during the freeze drying process the values of
these components in the control serum and the test will be calculated on the consensus value.
PAINKILLERS

The program includes 4 tests per year. The samples (5 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
PSYCHOTROPIC DRUGS

The program includes 4 tests per year. The samples (5 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
Psychotropic drugs I
Control serum I, II, III or IV (per 5 vials of 5 ml) Psychotropic drugs II
Psychotropic drugs III
Psychotropic drugs IV

VARIOUS DRUGS

The program includes 4 test per year with 1 or 2 samples of 5 ml with different components which are not often
tested in most of the laboratories but belong to the (sub)routine assays. The last years the following components
were tested: disopyramide, procaïnamide, quinidine, flunitrazepam, desmethylflunitrazepam, atenolol,
metoprolol, propanolol, sulfamethoxazole, trimethoprim, zuclopethixol etc.
The matrix is liquid or lyophilised bovine serum.
Participation

"DRUGS OF ABUSE"

The program includes 4 tests of 2 urine samples per year. The presence or absence of amphetamines, opiates,
cannabinoids, cocaine, benzodiazepines, ethanol, methadone, barbiturates and other drugs of abuse like GHB
needs to be established.
The matrix is human urine.
Participation
EXPERIMENTAL TDM

The program includes 4 tests of 1 or 2 samples of 5 ml. The samples contain 1 or 2 components.
Components tested in this program are new medicines or require difficult analysis or interpretation.
Participation

TOXICOLOGY

The program includes 4 or 5 tests per year. The samples (5 ml) contain different components and are presented
with a toxicological case.
The participant is supposed to perform a toxicological screening and is asked to give an advice for treatment.
The matrix is liquid of lyophilised bovine serum.
Participation

ANTIRETROVIRAL DRUGS

This program includes 2 rounds with 4 samples (2x Antiretrovirals I and 2x Antiretrovirals II) per year. The
samples (4 ml) contain the components listed below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
Antiretrovirals I
Control serum I or II (per 5 tubes of 2,5 ml) Matrix: liquid human serum, preserved with 0,1% Antiretrovirals II
ANTIFUNGAL DRUGS

This program includes 2 rounds with 2 samples per year. The samples (3 ml) contain the components listed
below.
Separate control serum is available with the same components. Concentrations are listed in the table below.
Components
Control serum
Matrix: liquid human serum, preserved with 0,1%
ANTITUBERCULOSIS DRUGS

Depending on the number of subscriptions for this program, the KKGT will offer this program in 2013.
On the subscription form the participant can state whether he is interested in this program. In case of sufficient
applications we will contact those interested for a definitive subscription.
Components
Matrix: liquid human serum, preserved with 0,1%
OTHER CONTROL SAMPLES

Components
Concentration
Matrix: urine, preserved with 0,1% sodium azide PRICE LIST 2013

Program
Price (excl. VAT)
Control samples
Price (excl. VAT)
You can order your control samples simultaneous with your subscription for 2013. For late orders of control samples the KKGT wil charge € 17,50 for administrative expenses and shipping. It is only possible to order control samples of a specific program for participants who are subscribed for this program. The control samples should not be used as reference material.

Source: http://www.kkgt.nl/invulformulieren/2013_EN%20general%20information.pdf

Microsoft word - reddy et al pdf.doc

Research In Pharmaceutical Biotechnology Vol. 2(1), pp. 001-006, February, 2010 Available online at http://www.academicjournals.org/RPB Validation and stability indicating RP-HPLC method for the determination of tadalafil API in pharmaceutical formulations B. Prasanna Reddy1*, K. Amarnadh Reddy2 and M. S. Reddy3 1Department of Quality control, Nosch Labs Pvt Ltd, Hyderabad-50007

Pii: s1062-1458(01)00215-x

Arrhythmias Neurocardiogenic Syncope: When and How to Treat? afforded considerable latitude in planning therapy based onBlair Grubb, MD and Daniel J. Kosinski, MD,the patient’s clinical circumstance. Electrophysiology Section, Division of Cardiology,In addition, it is our opinion that any patient withDepartment of Medicine, The Medical College of Ohio,neurocardiogenic syncope and

Copyright © 2010-2014 Medical Science